Ifs Securities reissued their outperform rating on shares of Aeon Global Health (OTCMKTS:AGHC) in a report issued on Wednesday morning.

AGHC opened at $0.87 on Wednesday.

About Aeon Global Health

AEON Global Health Corp., together with its subsidiaries, provides various clinical laboratory testing services in the United States. The company operates through two segments, Laboratory Testing Services and Web-Based Software. Its laboratory testing services include the testing of an individual's blood, urine, or saliva for the presence of drugs or chemicals, as well as the patient's DNA profile.

Recommended Story: Diversification in Investing

Receive News & Ratings for Aeon Global Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aeon Global Health and related companies with MarketBeat.com's FREE daily email newsletter.